Lung Cancer
Volume 65, Issue 3 , Pages 268-273 , September 2009

XRCC1 polymorphisms and lung cancer risk in Chinese populations: A meta-analysis

  • Huilie Zheng

      Affiliations

    • Department of Epidemiology and Statistics, School of Public Health, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
    • Department of Epidemiology and Statistics, School of Public Health, Medical College of Nanchang University, Nanchang, Jiangxi, China
  • ,
  • Zhongxu Wang

      Affiliations

    • National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing, China
  • ,
  • Xiuquan Shi

      Affiliations

    • Department of Epidemiology and Statistics, School of Public Health, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
  • ,
  • Zengzhen Wang

      Affiliations

    • Department of Epidemiology and Statistics, School of Public Health, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
    • Corresponding Author InformationCorresponding author at: Department of Epidemiology and Health Statistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Hangkong Road 13, 430030 Wuhan, PR China. Tel.: +86 27 83692725; fax: +86 27 83692725.

Received 19 November 2008 ,Revised 1 February 2009 ,Accepted 2 February 2009.

References 

  1. Pharoah PD, Dunning A, Ponder BA, Easton DF. Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer. 2004;4:850–860
  2. Neumann AS, Sturgis EM, Wei QY. Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: a review of molecular epidemiological studies. Mol Carcinog. 2005;42:65–92
  3. Freedman ND, Leitzmann MF, Hollenbeck AR, Schatzkin A, Abnet CC. Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. Lancet Oncol. 2008;9:649–656
  4. Bandera EV, Freudenheim JL, Vena JE. Alcohol consumption and lung cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev. 2001;10:813–821
  5. Armstrong B, Hutchinson E, Unwin J, Fletcher T. Lung cancer risk after exposure to polycyclic aromatic hydrocarbons: A review and meta-analysis. Environ Health Perspect. 2004;112:970–978
  6. Moulin JJ, Clavel T, Roy D, Dananché B, Marquis N, Févotte J, et al. Risk of lung cancer in workers producing stainless steel and metallic alloys. Int Arch Occup Environ Health. 2000;73:171–180
  7. Vineis P, Husgafvel-Pursiainen K. Air pollution and cancer: biomarker studies in human populations. Carcinogenesis. 2005;26:1846–1855
  8. Cleaver JE. Defective repair replication of DNA in xeroderma pigmentosum. Nature. 1968;218:652–656
  9. Caldecott KW, Tucker JD, Stanker LH, Thompson LH. Characterization of the XRCC1-DNA ligase III complex in vitro and its absence from mutant hamster cells. Nucleic Acids Res. 1995;23:4836–4843
  10. Dianov GL, Prasad R, Wilson SH, Bohr VA. Role of DNA polymerase in the excision step of long patch mammalian base excision repair. J Biol Chem. 1999;274:13741–13743
  11. Thompson LH, West MG. XRCC1 keeps DNA from getting stranded. Mutat Res. 2000;459:1–18
  12. Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res. 1999;59:2557–2561
  13. Duell EJ, Wiencke JK, Cheng TJ, Varkonyi A, Zuo ZF, Ashok TD, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis. 2000;21:965–971
  14. Matullo G, Guarrera S, Carturan S, Peluso M, Malaveille C, Davico L, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer. 2001;92:562–567
  15. Lei YC, Hwang SJ, Chang CC, Kuo HW, Luo JC, Chang MJ, et al. Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smokers. Mutat Res. 2002;519:93–101
  16. Hsieh LL, Chien HT, Chen IH, Liao CT, Wang HM, Jung SM, et al. The XRCC1 399Gln polymorphism and the frequency of p53 mutations in Taiwanese oral squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev. 2003;12:439–443
  17. Hu JJ, Smith TR, Miller MS, Mohrenweiser HW, Golden A, Case LD. Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis. 2001;22:917–922
  18. Taylor RM, Thistlethwaite A, Caldecott KW. Central role for the XRCC1 BRCT I domain in mammalian DNA single-strand break repair. Mol Cell Biol. 2002;22:2556–2563
  19. Pastorelli R, Cerri A, Mezzetti M, Consonni E, Airoldi L. Effect of DNA repair gene polymorphisms on BPDE-DNA adducts in human lymphocytes. Int J Cancer. 2002;100:9–13
  20. Gao WM, Romkes M, Day RD, Siegfried JM, Luketich JD, Mady HH, et al. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer. Carcinogenesis. 2003;24:1671–1676
  21. Hou SM, Ryk C, Kannio A, Angelini S, Fält S, Nyberg F, et al. Influence of common XPD and XRCC1 variant alleles on p53 mutations in lung tumors. Environ Mol Mutagen. 2003;41:37–42
  22. Wang Y, Spitz MR, Zhu Y, Dong Q, Shete S, Wu X. From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair. 2003;2:901–908
  23. Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst. 2000;92:874–897
  24. Lippman SM, Spitz MR. Lung cancer chemoprevention: an integrated approach. J Clin Oncol. 2001;19:S74–82
  25. Wei Q, Cheng L, Amos CI, Wang LE, Guo Z, Hong WK, et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst. 2000;92:1764–1772
  26. Wei Q, Cheng L, Hong WK, Spitz MR. Reduced DNA repair capacity in lung cancer patients. Cancer Res. 1996;56:4103–4107
  27. Rajaee-Behbahani N, Schmezer P, Risch A, Rittgen W, Kayser KW, Dienemann H, et al. Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancer. Int J Cancer. 2001;95:86–91
  28. Kiyohara C, Takayama K, Nakanishi Y. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer. 2006;54:267–283
  29. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634
  30. Chen S, Tang D, Xue K, Xu L, Ma G, Hsu Y, et al. DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis. 2002;23:1321–1325
  31. Song YH, Yin LH, Pu YP, Liang GY, Cui HM. Relationship between Polymorphisms of DNA repair gene XRCC1 and susceptibility to lung cancer in Nanjing population [in Chinese]. J Environ Occup Med. 2004;21:18–20
  32. Li JW, Mu LN, Wei GR, Chen CW, Zhang ZF, Yu SZ, et al. Relationship between polymorphisms of DNA repair gene XRCC1 and susceptibility to lung cancer [in Chinese]. China Oncol. 2005;15:335–338
  33. Zhang WJ, Wu YJ, Wu YM. Study on the polymorphism of XRCC1 gene G28152A and the risk of lung cancer [in Chinese]. Carcinogenesis. Teratog Mutagen. 2005;17:77–78
  34. Shen M, Berndt SI, Rothman N, Mumford JL, He X, Yeager M, et al. Polymorphisms in the DNA base excision repair genes APEX1 and XRCC1 and lung cancer risk in Xuan Wei, China. Anticancer Res. 2005;25:537–542
  35. Yu HP, Zeng XY, Qiu XQ, Xu SQ, Shi LY, Zhang XR, et al. Polymorphisms in the DNA repair gene XRCC1 and susceptibility to human lung cancer [in Chinese]. J Guangxi Med Univ. 2006;23:355–358
  36. Yin JY, Vogel U, Ma YG, Qi R, Sun ZF, Wang HW. The DNA repair gene XRCC1 and genetic susceptibility of lung cancer in a northeastern Chinese population. Lung Cancer. 2007;56:153–160
  37. Li MC, Yin ZH, Guan P, Li XL, Cui ZS, Zhang J, et al. XRCC1 polymorphisms, cooking oil fume and lung cancer in Chinese women nonsmokers. Lung Cancer. 2008;62:145–151[Epub ahead of print]
  38. Hung RJ, Hall J, Brennan P, Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol. 2005;162:925–942
  39. Hu ZB, Ma HX, Chen F, Wei QY, Shen HB. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev. 2005;14:1810–1818
  40. Ratnasinghe D, Yao SX, Tangrea JA, Qiao YL, Andersen MR, Barrett MJ, et al. Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2001;10:119–123
  41. David-Beabes GL, London SJ. Genetic polymorphism of XRCC1 and lungcancer risk among African-Americans and Caucasians. Lung Cancer. 2001;34:333–339

PII: S0169-5002(09)00066-X

doi: 10.1016/j.lungcan.2009.02.002

Lung Cancer
Volume 65, Issue 3 , Pages 268-273 , September 2009